Cite
MLA Citation
N Chanchlani et al.. “DOP62 Immunogenicity to second anti-TNF therapy (IMSAT): Implications for sequencing of biologic therapy.” Journal of Crohn's and colitis, vol. 15, n.d., pp. S097–S098. http://access.bl.uk/ark:/81055/vdc_100130765034.0x000009